MRE-269
Product Specifications
CAS Number
475085-57-5
Target
Prostaglandin Receptor
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Purity
0.9957
Bioactivity
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .
Smiles
N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2117686-01 1 mL
APC-Cy7 Linked Polyclonal Antibody to Tight Junction Protein 3 (TJP3)
Sign In for Pricing
View Details MBS2117686-02 5 mL
APC-Cy7 Linked Polyclonal Antibody to Tight Junction Protein 3 (TJP3)
Sign In for Pricing
View Details MBS2117686-03 5x 5 mL
APC-Cy7 Linked Polyclonal Antibody to Tight Junction Protein 3 (TJP3)
Sign In for Pricing
View Details MB3311 50ul
Acetyl-NF-KB p65 (Lys314/Lys315) (5F4) monoclonal antibody
Sign In for Pricing
View Details MBS1485863-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O6 Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Sign In for Pricing
View Details MBS1485863-02 0.02 mg (Yeast)
Recombinant Escherichia coli O6 Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Sign In for Pricing
View Details